Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT01895725

Correlation of Artherosclerotic Plaque Volume and Intima Media Thickness With Soluble P-selectin

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
443 (actual)
Sponsor
Medical University Innsbruck · Academic / Other
Sex
All
Age
30 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The proposed project is a prospective observational, single-center cohort study aimed to examine the progression of atherosclerotic alterations of the carotid arteries (IMT, plaque volume) during a follow-up of up to four years and to correlate the observed changes with traditional and novel biomarkers of atherosclerosis. A total of 600 subsequent patients with or established cardiovascular disease or at least one cardiovascular risk will be tested with a high-frequency ultrasound probe equipped with automated IMT measurements and 3D quantitative plaque volumetry. Plasma samples will be collected and tested for traditional and novel cardiovascular risk factors. Both ultrasound examinations and blood sampling will be repeated once per year to assess changes in these parameters over time depending on treatment modalities, which are left to the discretion of the treating physicians. The primary endpoint of the planned study will be the correlation between P-selectin and the progression of atherosclerosis as measured by plaque volume and IMT in the carotid and femoral arteries, respectively. Secondary endpoints will include the correlation of established (hypertension, smoking, diabetes, dyslipidemia) and novel risk factors (hsCRP, P-selectin, cholesteryl ester transfer protein (CETP), intercellular adhesion molecule-1 (ICAM-1), CETP TaqIb polymorphism) with the progression of atherosclerosis, the correlation of cardiovascular events with the progression of atherosclerosis and the additional predictive value of plaque volume and IMT compared to an established risk score (SCORE card).

Conditions

Timeline

Start date
2013-06-01
Primary completion
2020-01-30
Completion
2028-01-01
First posted
2013-07-10
Last updated
2021-05-14

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01895725. Inclusion in this directory is not an endorsement.